169 related articles for article (PubMed ID: 31091244)
1. Single nucleotide polymorphisms within MUC4 are associated with colorectal cancer survival.
Lu S; Catalano C; Huhn S; Pardini B; Partu L; Vymetalkova V; Vodickova L; Levy M; Buchler T; Hemminki K; Vodicka P; Försti A
PLoS One; 2019; 14(5):e0216666. PubMed ID: 31091244
[TBL] [Abstract][Full Text] [Related]
2. Single nucleotide polymorphisms within interferon signaling pathway genes are associated with colorectal cancer susceptibility and survival.
Lu S; Pardini B; Cheng B; Naccarati A; Huhn S; Vymetalkova V; Vodickova L; Buchler T; Hemminki K; Vodicka P; Försti A
PLoS One; 2014; 9(10):e111061. PubMed ID: 25350395
[TBL] [Abstract][Full Text] [Related]
3. Polymorphisms in microRNA binding sites of mucin genes as predictors of clinical outcome in colorectal cancer patients.
Vymetalkova V; Pardini B; Rosa F; Jiraskova K; Di Gaetano C; Bendova P; Levy M; Veskrnova V; Buchler T; Vodickova L; Naccarati A; Vodicka P
Carcinogenesis; 2017 Jan; 38(1):28-39. PubMed ID: 27803053
[TBL] [Abstract][Full Text] [Related]
4. Genetic variants in C-type lectin genes are associated with colorectal cancer susceptibility and clinical outcome.
Lu S; Bevier M; Huhn S; Sainz J; Lascorz J; Pardini B; Naccarati A; Vodickova L; Novotny J; Hemminki K; Vodicka P; Försti A
Int J Cancer; 2013 Nov; 133(10):2325-33. PubMed ID: 23650115
[TBL] [Abstract][Full Text] [Related]
5. Short article: Influence of regulatory NLRC5 variants on colorectal cancer survival and 5-fluorouracil-based chemotherapy.
Catalano C; da Silva Filho MI; Jiraskova K; Vymetalkova V; Levy M; Liska V; Vycital O; Naccarati A; Vodickova L; Hemminki K; Vodicka P; Weber ANR; Försti A
Eur J Gastroenterol Hepatol; 2018 Aug; 30(8):838-842. PubMed ID: 29762254
[TBL] [Abstract][Full Text] [Related]
6. Expression of membrane-bound mucins (MUC1 and MUC4) and secreted mucins (MUC2, MUC5AC, MUC5B, MUC6 and MUC7) in mucoepidermoid carcinomas of salivary glands.
Alos L; Lujan B; Castillo M; Nadal A; Carreras M; Caballero M; de Bolos C; Cardesa A
Am J Surg Pathol; 2005 Jun; 29(6):806-13. PubMed ID: 15897748
[TBL] [Abstract][Full Text] [Related]
7. Genetic variants of MUC4 are associated with susceptibility to and mortality of colorectal cancer and exhibit synergistic effects with LDL-C levels.
Kwon MJ; Lee JY; Kim EJ; Ko EJ; Ryu CS; Cho HJ; Jun HH; Kim JW; Kim NK
PLoS One; 2023; 18(6):e0287768. PubMed ID: 37384668
[TBL] [Abstract][Full Text] [Related]
8. Functional polymorphisms of ATP citrate lyase gene predicts clinical outcome of patients with advanced colorectal cancer.
Xie S; Zhou F; Wang J; Cao H; Chen Y; Liu X; Zhang Z; Dai J; He X
World J Surg Oncol; 2015 Feb; 13():42. PubMed ID: 25890184
[TBL] [Abstract][Full Text] [Related]
9. Single nucleotide polymorphisms within MicroRNAs, MicroRNA targets, and MicroRNA biogenesis genes and their impact on colorectal cancer survival.
Mullany LE; Herrick JS; Wolff RK; Slattery ML
Genes Chromosomes Cancer; 2017 Apr; 56(4):285-295. PubMed ID: 27859935
[TBL] [Abstract][Full Text] [Related]
10. Common Genetic Variants of PSCA, MUC1 and PLCE1 Genes are not Associated with Colorectal Cancer.
Kupcinskas J; Gyvyte U; Bruzaite I; Leja M; Kupcinskaite-Noreikiene R; Pauzas H; Tamelis A; Jonaitis L; Skieceviciene J; Kiudelis G
Asian Pac J Cancer Prev; 2015; 16(14):6027-32. PubMed ID: 26320491
[TBL] [Abstract][Full Text] [Related]
11. Aberrant methylation of MUC1 and MUC4 promoters are potential prognostic biomarkers for pancreatic ductal adenocarcinomas.
Yokoyama S; Higashi M; Kitamoto S; Oeldorf M; Knippschild U; Kornmann M; Maemura K; Kurahara H; Wiest E; Hamada T; Kitazono I; Goto Y; Tasaki T; Hiraki T; Hatanaka K; Mataki Y; Taguchi H; Hashimoto S; Batra SK; Tanimoto A; Yonezawa S; Hollingsworth MA
Oncotarget; 2016 Jul; 7(27):42553-42565. PubMed ID: 27283771
[TBL] [Abstract][Full Text] [Related]
12. Colorectal cancer risk and patients' survival: influence of polymorphisms in genes somatically mutated in colorectal tumors.
Huhn S; Bevier M; Pardini B; Naccarati A; Vodickova L; Novotny J; Vodicka P; Hemminki K; Försti A
Cancer Causes Control; 2014 Jun; 25(6):759-69. PubMed ID: 24706189
[TBL] [Abstract][Full Text] [Related]
13. Association between GWAS-identified genetic variations and disease prognosis for patients with colorectal cancer.
Kang BW; Jeon HS; Chae YS; Lee SJ; Park JY; Choi JE; Park JS; Choi GS; Kim JG
PLoS One; 2015; 10(3):e0119649. PubMed ID: 25799222
[TBL] [Abstract][Full Text] [Related]
14. MUC1, MUC2, MUC5AC, and MUC6 in colorectal cancer: expression profiles and clinical significance.
Betge J; Schneider NI; Harbaum L; Pollheimer MJ; Lindtner RA; Kornprat P; Ebert MP; Langner C
Virchows Arch; 2016 Sep; 469(3):255-65. PubMed ID: 27298226
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical expression profiles of mucin antigens in salivary gland mucoepidermoid carcinoma: MUC4- and MUC6-negative expression predicts a shortened survival in the early postoperative phase.
Honjo K; Hiraki T; Higashi M; Noguchi H; Nomoto M; Yoshimura T; Batra SK; Yonezawa S; Semba I; Nakamura N; Tanimoto A; Yamada S
Histol Histopathol; 2018 Feb; 33(2):201-213. PubMed ID: 28649694
[TBL] [Abstract][Full Text] [Related]
16. [Expression and clinical significance of Mucin and E-cadherin in colorectal tumors].
Yu XW; Rong W; Xu FL; Xu GY; Sun YR; Feng MY
Ai Zheng; 2007 Nov; 26(11):1204-10. PubMed ID: 17991319
[TBL] [Abstract][Full Text] [Related]
17. Predictive impact of genetic polymorphisms in DNA repair genes on susceptibility and therapeutic outcomes to colorectal cancer patients.
Sun K; Gong A; Liang P
Tumour Biol; 2015 Mar; 36(3):1549-59. PubMed ID: 25355595
[TBL] [Abstract][Full Text] [Related]
18. XRCC1 and ERCC1 polymorphisms are related to susceptibility and survival of colorectal cancer in the Chinese population.
Dai Q; Luo H; Li XP; Huang J; Zhou TJ; Yang ZH
Mutagenesis; 2015 May; 30(3):441-9. PubMed ID: 25690281
[TBL] [Abstract][Full Text] [Related]
19. Mucin gene polymorphisms are associated with endometriosis in Korean women.
Kim JH; Kim TH; Kim YS; Jang WC; Ryu A; Hwang JY; Lee HH
Arch Gynecol Obstet; 2020 Mar; 301(3):801-807. PubMed ID: 31858233
[TBL] [Abstract][Full Text] [Related]
20. Case-control study for colorectal cancer genetic susceptibility in EPICOLON: previously identified variants and mucins.
Abulí A; Fernández-Rozadilla C; Alonso-Espinaco V; Muñoz J; Gonzalo V; Bessa X; González D; Clofent J; Cubiella J; Morillas JD; Rigau J; Latorre M; Fernández-Bañares F; Peña E; Riestra S; Payá A; Jover R; Xicola RM; Llor X; Carvajal-Carmona L; Villanueva CM; Moreno V; Piqué JM; Carracedo A; Castells A; Andreu M; Ruiz-Ponte C; Castellví-Bel S;
BMC Cancer; 2011 Aug; 11():339. PubMed ID: 21819567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
